In comments submitted to the US Center for Medicare and Medicaid Services, industry members asked for greater transparency and eligibility for the office’s Transitional Coverage for Emerging Technologies (TCET) pathway.
Expanding Device Eligibility And Other Suggestions For CMS’s TCET Pathway
Comments submitted by industry members about CMS’s TCET notice highlight the need for greater device eligibility and transparency for the pathway.
More from Policy & Regulation
More from Medtech Insight
• By
About 200 staff in the FDA’s Center for Devices and Radiological Health were among the 3,500 FDA employees let go in today’s staff reductions. The cuts, which one employee described as a “Manhattan Project” to the center, are already having a major effect on staff morale.
• By
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
AdvaMed’s top priorities for the 119th Congress include modernizing US Medicare services and expanding patients’ access to the latest medical technologies.